Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors:<i> A Systematic Review and Meta-Analysis</i>

<div>Forest plot for the Grade classification (G1&amp;G2/G3) of liver resection group and nonliver resection group in patients with liver metastases from pancreatic neuroendocrine tumor. There is no significant difference between two groups.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors:<i> A Systematic Review and Meta-Analysis</i> 

Figure 3 | Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis 